INSIGHTS ON DRUG DEVELOPMENT
-
Mitigating Early Development Risks
Discover how the efficient screening of biologic candidates accelerates the discovery process, reduces costs, and improves the likelihood of commercializing safe and effective drugs.
-
Exosome Production From hMSC Using A Fixed-Bed Bioreactor
Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.
-
Design Scalable Downstream Processes With Practical Strategies
Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.
-
CDMOs - Key Collaborators In Streamlining Drug Development
Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.
-
T3P – A Green Solution For Peptide Coupling, Water Removal Reactions1/13/2026
The session focuses on the use of T3P (propanephosphonic acid anhydride) in amidation and peptide coupling reactions, including both liquid-phase and solid-phase peptide synthesis.
-
Improved Cell Viability For Multi-Day Cell-Based Assays7/24/2025
Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.
-
How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions8/11/2025
With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence
-
Why Emerging Drug Developers Can't Afford To Delay Analytical Development5/21/2026
Rushing early pharma development by neglecting quality and analytical frameworks risks regulatory failures, clinical holds, and expensive rework.
-
The 5 Ws Of A Human Factors Strategy3/31/2025
A human factors strategy ensures medical products are safe, effective, and compliant by integrating user-focused design early, reducing risks, and optimizing regulatory approval processes.
DRUG DEVELOPMENT SOLUTIONS
-
A60 F Stereo Microscope
Optimize your productivity and production quality
The intuitive A60 F and A60 S stereo microscopes fulfill what you need – high sample throughput, optimum visibility of product details and components, and easy processing of subassemblies.
-
See 80% more of your sample with a 46 mm object field
-
Comfortable access your sample due to the 122 mm working distance
-
Easy handling, less refocusing and time saving with up to 13.6 mm depth of field and Leica FusionOptics technology
-
Enables large surface overview and detailed observation with a magnification range from 5x to 30x
-
-
Learn how strategic filtration safeguards chromatography systems, improves sample quality, and supports efficient protein purification to create smoother, more reliable workflows.
-
Leica DM2000 LED - Ergonomic System Microscopes for Complex Clinical Applications
-
The commercialization of a combination product can be a complex process that involves obtaining the proper data, choosing a drug delivery system, developing a regulatory strategy and conducting clinical trials—all of which can increase development risks and affect your molecule’s time to market.
-
We care about quality because you care about your data. Every day you produce data which enables decisions that are consequential to human health, food quality, and the environment.